Skip to main content
Market intelligence
ZOMDFSector not reported

Zomedica Corp. insider activity

In the last 90 days, 2 corporate insiders purchased $142,218 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$142,218
Corporate buyers
2
Latest transaction
May 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 21, 2026Russell Kevin KlassSr. Vice President, SalesOpen Market Purchase104,000$0.10$10,712
May 21, 2026Russell Kevin KlassCorporate insiderOpen Market Purchase216,899$0.11$22,796
May 20, 2026Johnny D PowersDirectorOpen Market Purchase200,000$0.10$20,600